Genome-wide association study of 1,5-anhydroglucitol identifies novel genetic loci linked to glucose metabolism

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Li, Man ^a,b   Maruthur, Nisa M ^a,c,d   Loomis, Stephanie J ^a   Pietzner, Maik ^e,f   North, Kari E ^g   Mei, Hao ^h   Morrison, Alanna C ⁱ   Friedrich, Nele ^e,f   Pankow, James S ^j   Nauck, Matthias ^e,f   Boerwinkle, Eric ^i,k   Teumer, Alexander ^e,f   Selvin, Elizabeth ^a,c,d   Köttgen, Anna ^a,l  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^g IL   (United States)

^h UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^j UNIVERSITY OF MINNESOTA   (United States)

^k BAYLOR COLLEGE OF MEDICINE   (United States)

^l UNIVERSITY OF FREIBURG   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

1,5-ANHYDROGLUCITOL; DEOXYGLUCOSE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN; MCM6 PROTEIN, HUMAN; MINICHROMOSOME MAINTENANCE PROTEIN 6; SLC5A1 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 1;

AFRICAN AMERICAN; AGED; CAUCASIAN; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; HYPERGLYCEMIA; MALE; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY;

AFRICAN AMERICANS; AGED; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GLUCOSE; GLYCATED HEMOGLOBIN A; HUMANS; HYPERGLYCEMIA; INSULIN; MALE; MIDDLE AGED; MINICHROMOSOME MAINTENANCE COMPLEX COMPONENT 6; SODIUM-GLUCOSE TRANSPORTER 1;

EID: 85020376545     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02287-x     Document Type: Article

References (40)

1. Parrinello, C. M., & Selvin, E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Current diabetes reports 14, 548, doi: 10.1007/s11892-014-0548-3 (2014
2. Dworacka, M., et al. 1,5-anhydro-D-glucitol: a novel marker of glucose excursions. International journal of clinical practice. Supplement, 40-44 (2002
3. Buse, J. B., Freeman, J. L., Edelman, S. V., Jovanovic, L., & McGill, J. B. Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker. Diabetes technology, & therapeutics 5, 355-363, doi: 10.1089/152091503765691839 (2003
4. Dungan, K. M. 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions. Expert review of molecular diagnostics 8, 9-19, doi: 10.1586/14737159.8.1.9 (2008
5. Selvin, E., et al. Association of 1,5-Anhydroglucitol With Cardiovascular Disease and Mortality. Diabetes 65, 201-208, doi: 10.2337/db15-0607 (2016
6. Selvin, E., et al. Association of 1,5-anhydroglucitol with diabetes and microvascular conditions. Clin Chem 60, 1409-1418, doi: 10.1373/clinchem.2014.229427 (2014
7. Ikeda, N., Hara, H., Hiroi, Y., & Nakamura, M. Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease. Atherosclerosis 253, 1-6, doi: 10.1016/j. atherosclerosis.2016.08.016 (2016
8. Kuroda, M., et al. Effect of daily glucose fluctuation on coronary plaque vulnerability in patients pre-treated with lipid-lowering therapy: a prospective observational study. JACC. Cardiovascular interventions 8, 800-811, doi: 10.1016/j.jcin.2014.11.025 (2015
9. Shin, S.-Y., et al. An atlas of genetic influences on human blood metabolites. Nat Genet 46, 543-550, doi: 10.1038/ng.2982 http://www. nature.com/ng/journal/v46/n6/abs/ng.2982.html -supplementary-information (2014
10. Suhre, K., et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 477, 54-60, doi: 10.1038/nature10354 (2011
11. Dupuis, J., et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature genetics 42, 105-116, doi: 10.1038/ng.520 (2010
12. Soranzo, N., et al. Common variants at 10 genomic loci influence hemoglobin A(1)(C) levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239, doi: 10.2337/db10-0502 (2010
13. Olds, L. C., & Sibley, E. Lactase persistence DNA variant enhances lactase promoter activity in vitro: functional role as a cis regulatory element. Hum Mol Genet 12, 2333-2340, doi: 10.1093/hmg/ddg244 (2003
14. Joshi, S. R., et al. Therapeutic potential of alpha-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review. Expert opinion on pharmacotherapy 16, 1959-1981, doi: 10.1517/14656566.2015.1070827 (2015
15. Ghani, U. Re-exploring promising alpha-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack. European journal of medicinal chemistry 103, 133-162, doi: 10.1016/j.ejmech.2015.08.043 (2015
16. Polonsky, K. S., Given, B. D., & Van Cauter, E. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest 81, 442-448, doi: 10.1172/jci113339 (1988
17. Tsukuda, K., et al. Evaluation of the 24-hour profiles of physiological insulin, glucose, and C-peptide in healthy Japanese volunteers. Diabetes technology, & therapeutics 11, 499-508, doi: 10.1089/dia.2009.0029 (2009
18. Uhlen, M., et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419-1260419, doi: 10.1126/science.1260419 (2015
19. Grempler, R., et al. Functional characterisation of human SGLT-5 as a novel kidney-specific sodium-dependent sugar transporter. FEBS Lett 586, 248-253, doi: 10.1016/j.febslet.2011.12.027 (2012
20. Fukuzawa, T., et al. SGLT5 reabsorbs fructose in the kidney but its deficiency paradoxically exacerbates hepatic steatosis induced by fructose. PLoS One 8, e56681, doi: 10.1371/journal.pone.0056681 (2013
21. Wright, E. M. Glucose transport families SLC5 and SLC50. Molecular aspects of medicine 34, 183-196, doi: 10.1016/j. mam.2012.11.002 (2013
22. Long T., et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat Genet. 49(4), 568-578 (2017
23. Chen, L. Q., et al. Sugar transporters for intercellular exchange and nutrition of pathogens. Nature 468, 527-532, doi: 10.1038/nature09606 (2010
24. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. American Journal of Epidemiology 129, 687-702 (1989
25. Maruthur, N. M., et al. Genetics of Plasma Soluble Receptor for Advanced Glycation End-Products and Cardiovascular Outcomes in a Community-based Population: Results from the Atherosclerosis Risk in Communities Study. PLoS One 10, e0128452, doi: 10.1371/journal.pone.0128452 (2015
26. Delaneau, O., Zagury, J. F., & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nature methods 10, 5-6, doi: 10.1038/nmeth.2307 (2013
27. Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nature genetics 44, 955-959, doi: 10.1038/ng.2354 (2012
28. Price, A. L., et al. Principal components analysis corrects for stratification in genome-wide association studies. Nature genetics 38, 904-909, doi: 10.1038/ng1847 (2006
29. Selvin, E., et al. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med 154, 303-309, doi: 10.7326/0003-4819-154-5-201103010-00004 (2011
30. Selvin, E., Coresh, J., Zhu, H., Folsom, A., & Steffes, M. W. Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study. Journal of diabetes 2, 118-124, doi: 10.1111/j.1753-0407.2010.00070.x (2010
31. J. Marchini, et al. A new multipoint method for genome-wide association studies via imputation of genotypes. Nature Genetics. 39, 906-913 (2007
32. Bush, W. S., & Moore, J. H. Chapter 11: Genome-Wide Association Studies. PLoS Comput Biol 8, e1002822, doi: 10.1371/journal. pcbi.1002822 (2012
33. Pe?er, I., Yelensky, R., Altshuler, D., & Daly, M. J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32, 381-385, doi: 10.1002/gepi.20303 (2008
34. Pruim, R. J., et al. LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics (Oxford, England) 26, 2336-2337, doi: 10.1093/bioinformatics/btq419 (2010
35. Purcell, S., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. American Journal of Human Genetics 81, 559-575, doi: 10.1086/519795 (2007
36. Moayyeri, A., Hammond, C. J., Hart, D. J., & Spector, T. D. The UK Adult Twin Registry (TwinsUK Resource). Twin research and human genetics: the official journal of the International Society for Twin Studies 16, 144-149, doi: 10.1017/thg.2012.89 (2013
37. Wichmann, H. E., Gieger, C., & Illig, T. KORA-gen-resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen (Bundesverband Der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 67(Suppl 1), S26-30, doi: 10.1055/s-2005-858226 (2005
38. Volzke, H., et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol 40, 294-307, doi: 10.1093/ije/dyp394 (2011
39. Knacke, H., et al. Metabolic Fingerprints of Circulating IGF-1 and the IGF-1/IGFBP-3 Ratio: A Multifluid Metabolomics Study. The Journal of clinical endocrinology and metabolism 101, 4730-4742, doi: 10.1210/jc.2016-2588 (2016
40. Willer, C. J., Li, Y., & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (Oxford, England) 26, 2190-2191, doi: 10.1093/bioinformatics/btq340 (2010